Jayashri Aragam, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ventricular Dysfunction, Left | 14 | 2020 | 2145 | 1.000 |
Why?
|
Echocardiography | 30 | 2020 | 5047 | 0.840 |
Why?
|
Ventricular Function, Left | 18 | 2024 | 3941 | 0.810 |
Why?
|
Echocardiography, Transesophageal | 7 | 2020 | 1096 | 0.730 |
Why?
|
Heart Ventricles | 16 | 2018 | 3841 | 0.670 |
Why?
|
Sinus of Valsalva | 1 | 2017 | 60 | 0.560 |
Why?
|
Hypertrophy, Left Ventricular | 8 | 2017 | 856 | 0.550 |
Why?
|
Bioprosthesis | 1 | 2020 | 593 | 0.520 |
Why?
|
Heart Valve Prosthesis | 3 | 2020 | 1468 | 0.490 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2020 | 615 | 0.470 |
Why?
|
Atrial Function, Left | 4 | 2018 | 188 | 0.450 |
Why?
|
Stroke Volume | 11 | 2024 | 5622 | 0.410 |
Why?
|
Aortic Aneurysm | 1 | 2017 | 649 | 0.410 |
Why?
|
Aneurysm, Ruptured | 1 | 2017 | 455 | 0.400 |
Why?
|
Ventricular Remodeling | 9 | 2019 | 1281 | 0.390 |
Why?
|
Aortic Diseases | 4 | 2013 | 741 | 0.340 |
Why?
|
Heart Failure | 15 | 2024 | 11879 | 0.310 |
Why?
|
Hypertension, Pulmonary | 4 | 2014 | 1605 | 0.310 |
Why?
|
Thrombosis | 2 | 2020 | 2957 | 0.300 |
Why?
|
Echocardiography, Doppler | 5 | 2017 | 898 | 0.300 |
Why?
|
Heart Atria | 7 | 2018 | 1361 | 0.300 |
Why?
|
Pulmonary Artery | 2 | 2013 | 1946 | 0.270 |
Why?
|
Pheochromocytoma | 2 | 2008 | 328 | 0.270 |
Why?
|
LEOPARD Syndrome | 1 | 2005 | 12 | 0.250 |
Why?
|
Noonan Syndrome | 1 | 2006 | 122 | 0.250 |
Why?
|
Veterans | 2 | 2023 | 2669 | 0.240 |
Why?
|
Mitral Valve | 2 | 2020 | 1475 | 0.230 |
Why?
|
Heart Valve Diseases | 3 | 2016 | 1030 | 0.230 |
Why?
|
Dilatation, Pathologic | 1 | 2005 | 527 | 0.220 |
Why?
|
Myocardial Contraction | 3 | 2015 | 1525 | 0.210 |
Why?
|
Tricuspid Valve | 1 | 2006 | 419 | 0.210 |
Why?
|
Cardiovascular Diseases | 13 | 2019 | 15662 | 0.210 |
Why?
|
Shock | 1 | 2005 | 316 | 0.200 |
Why?
|
Heart Septal Defects, Atrial | 2 | 2014 | 452 | 0.190 |
Why?
|
Diastole | 3 | 2020 | 785 | 0.190 |
Why?
|
Sarcoidosis | 1 | 2006 | 535 | 0.180 |
Why?
|
Cardiac Tamponade | 1 | 2001 | 175 | 0.180 |
Why?
|
Embolism | 2 | 2011 | 401 | 0.170 |
Why?
|
Cardiomyopathies | 3 | 2008 | 2056 | 0.170 |
Why?
|
Dyspnea | 3 | 2014 | 1352 | 0.170 |
Why?
|
Hemangiosarcoma | 1 | 2001 | 215 | 0.160 |
Why?
|
Exercise Tolerance | 1 | 2024 | 846 | 0.160 |
Why?
|
Echocardiography, Doppler, Color | 2 | 2017 | 353 | 0.150 |
Why?
|
Heart Neoplasms | 1 | 2001 | 374 | 0.150 |
Why?
|
Extracellular Matrix Proteins | 1 | 2021 | 832 | 0.140 |
Why?
|
Prognosis | 14 | 2024 | 30010 | 0.140 |
Why?
|
Calcium-Binding Proteins | 1 | 2021 | 1083 | 0.140 |
Why?
|
Coronary Circulation | 2 | 1993 | 1617 | 0.130 |
Why?
|
Male | 55 | 2024 | 364719 | 0.130 |
Why?
|
Aortic Valve Stenosis | 2 | 2023 | 2032 | 0.130 |
Why?
|
Superior Vena Cava Syndrome | 1 | 1996 | 56 | 0.130 |
Why?
|
Middle Aged | 43 | 2024 | 223492 | 0.130 |
Why?
|
Prosthesis Failure | 1 | 2020 | 1208 | 0.120 |
Why?
|
Aorta, Thoracic | 2 | 2013 | 1110 | 0.120 |
Why?
|
Adipokines | 1 | 2017 | 309 | 0.120 |
Why?
|
Massachusetts | 11 | 2018 | 8890 | 0.120 |
Why?
|
Humans | 64 | 2024 | 768166 | 0.120 |
Why?
|
Blood Pressure | 8 | 2021 | 8543 | 0.110 |
Why?
|
Quantitative Trait, Heritable | 1 | 2017 | 540 | 0.110 |
Why?
|
Risk Assessment | 9 | 2019 | 24315 | 0.110 |
Why?
|
Risk Factors | 24 | 2018 | 74944 | 0.110 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2013 | 69 | 0.110 |
Why?
|
Aged | 33 | 2024 | 171504 | 0.110 |
Why?
|
Carbonated Beverages | 1 | 2014 | 210 | 0.110 |
Why?
|
Scimitar Syndrome | 1 | 2013 | 30 | 0.110 |
Why?
|
Prevalence | 8 | 2019 | 15869 | 0.100 |
Why?
|
Female | 44 | 2024 | 397192 | 0.100 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2013 | 277 | 0.100 |
Why?
|
Predictive Value of Tests | 8 | 2017 | 15454 | 0.100 |
Why?
|
Neoplasms | 1 | 2020 | 22371 | 0.100 |
Why?
|
Incidence | 12 | 2018 | 21538 | 0.090 |
Why?
|
Heart Diseases | 2 | 2017 | 2819 | 0.090 |
Why?
|
Hospitals, Veterans | 1 | 2013 | 395 | 0.090 |
Why?
|
Septal Occluder Device | 1 | 2011 | 126 | 0.090 |
Why?
|
Longitudinal Studies | 9 | 2021 | 14783 | 0.090 |
Why?
|
Multivariate Analysis | 8 | 2017 | 12077 | 0.090 |
Why?
|
Heart | 2 | 2020 | 4446 | 0.090 |
Why?
|
Resistin | 1 | 2011 | 172 | 0.090 |
Why?
|
Vascular Resistance | 1 | 2013 | 939 | 0.090 |
Why?
|
Foreign-Body Migration | 1 | 2011 | 220 | 0.080 |
Why?
|
Sarcomeres | 1 | 2012 | 380 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2023 | 16045 | 0.080 |
Why?
|
Phosphorus | 1 | 2010 | 336 | 0.080 |
Why?
|
Foramen Ovale, Patent | 1 | 2011 | 210 | 0.080 |
Why?
|
Systole | 3 | 2017 | 937 | 0.080 |
Why?
|
Delayed Diagnosis | 1 | 2013 | 467 | 0.080 |
Why?
|
Genome-Wide Association Study | 4 | 2023 | 12795 | 0.080 |
Why?
|
Elasticity Imaging Techniques | 1 | 2013 | 398 | 0.080 |
Why?
|
Aged, 80 and over | 9 | 2017 | 59629 | 0.080 |
Why?
|
Exercise Test | 2 | 2024 | 2186 | 0.070 |
Why?
|
Adult | 24 | 2020 | 223646 | 0.070 |
Why?
|
Genetic Loci | 1 | 2017 | 2629 | 0.070 |
Why?
|
Fistula | 1 | 1989 | 213 | 0.070 |
Why?
|
Heart Septum | 1 | 2008 | 304 | 0.070 |
Why?
|
Catecholamines | 1 | 2008 | 389 | 0.070 |
Why?
|
Obesity | 5 | 2023 | 13090 | 0.070 |
Why?
|
Aging | 3 | 2010 | 8744 | 0.070 |
Why?
|
Thyrotropin | 1 | 2010 | 834 | 0.070 |
Why?
|
Anticoagulants | 2 | 2020 | 4852 | 0.070 |
Why?
|
Stress, Physiological | 1 | 2013 | 1408 | 0.060 |
Why?
|
Brachial Artery | 1 | 2007 | 373 | 0.060 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2006 | 224 | 0.060 |
Why?
|
Endocarditis, Bacterial | 1 | 1989 | 436 | 0.060 |
Why?
|
Adiponectin | 1 | 2011 | 1117 | 0.060 |
Why?
|
Follow-Up Studies | 9 | 2019 | 39348 | 0.060 |
Why?
|
Receptors, Adrenergic | 1 | 2005 | 155 | 0.060 |
Why?
|
Time Factors | 6 | 2019 | 40218 | 0.060 |
Why?
|
Tendons | 1 | 2009 | 556 | 0.060 |
Why?
|
Heart Block | 1 | 2006 | 390 | 0.060 |
Why?
|
Arginine | 1 | 2008 | 932 | 0.060 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2006 | 458 | 0.060 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2006 | 262 | 0.060 |
Why?
|
Myocardium | 1 | 2017 | 4788 | 0.060 |
Why?
|
Aorta | 2 | 2009 | 2045 | 0.060 |
Why?
|
Severity of Illness Index | 4 | 2016 | 15948 | 0.060 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2012 | 1334 | 0.050 |
Why?
|
Thyroid Gland | 1 | 2010 | 1171 | 0.050 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2008 | 735 | 0.050 |
Why?
|
Longevity | 1 | 2010 | 1077 | 0.050 |
Why?
|
Norepinephrine | 1 | 2005 | 898 | 0.050 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2006 | 362 | 0.050 |
Why?
|
Linear Models | 4 | 2014 | 5884 | 0.050 |
Why?
|
Disease Progression | 6 | 2018 | 13671 | 0.050 |
Why?
|
Sex Factors | 5 | 2014 | 10632 | 0.050 |
Why?
|
Hypertension | 5 | 2018 | 8616 | 0.050 |
Why?
|
Coronary Vessels | 1 | 1993 | 3124 | 0.050 |
Why?
|
Pulmonary Embolism | 1 | 1995 | 2599 | 0.050 |
Why?
|
Regression Analysis | 4 | 2010 | 6340 | 0.050 |
Why?
|
Atrial Fibrillation | 2 | 2018 | 5176 | 0.050 |
Why?
|
Leptin | 1 | 2009 | 1599 | 0.050 |
Why?
|
Coronary Disease | 1 | 2015 | 5919 | 0.050 |
Why?
|
Heart Defects, Congenital | 2 | 2009 | 4712 | 0.050 |
Why?
|
Heart Conduction System | 1 | 2006 | 1009 | 0.050 |
Why?
|
Pulsatile Flow | 2 | 2010 | 320 | 0.040 |
Why?
|
Proportional Hazards Models | 4 | 2018 | 12543 | 0.040 |
Why?
|
Troponin I | 2 | 2016 | 662 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2006 | 13014 | 0.040 |
Why?
|
Natriuretic Peptide, Brain | 3 | 2016 | 1751 | 0.040 |
Why?
|
Organ Size | 3 | 2010 | 2267 | 0.040 |
Why?
|
United States | 7 | 2019 | 73039 | 0.040 |
Why?
|
Muscle Strength | 1 | 2024 | 640 | 0.040 |
Why?
|
Lipoproteins, LDL | 1 | 2023 | 644 | 0.040 |
Why?
|
Thromboembolism | 1 | 2006 | 1004 | 0.040 |
Why?
|
Stress, Mechanical | 2 | 2015 | 1676 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2013 | 3929 | 0.040 |
Why?
|
Ultrasonography | 4 | 2015 | 6004 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 4055 | 0.040 |
Why?
|
Myocardial Infarction | 2 | 2016 | 11519 | 0.040 |
Why?
|
Lipoprotein(a) | 1 | 2023 | 489 | 0.040 |
Why?
|
Aldosterone | 2 | 2016 | 881 | 0.040 |
Why?
|
Oxygen Consumption | 1 | 2024 | 1880 | 0.040 |
Why?
|
Sex Distribution | 2 | 2014 | 2278 | 0.040 |
Why?
|
Clinical Competence | 1 | 2013 | 4858 | 0.040 |
Why?
|
Electrocardiography | 4 | 2014 | 6412 | 0.040 |
Why?
|
Genetic Variation | 1 | 2012 | 6611 | 0.030 |
Why?
|
Odds Ratio | 3 | 2016 | 9669 | 0.030 |
Why?
|
Registries | 1 | 2013 | 8375 | 0.030 |
Why?
|
Models, Cardiovascular | 2 | 2012 | 981 | 0.030 |
Why?
|
Venous Thrombosis | 1 | 2006 | 1323 | 0.030 |
Why?
|
Diabetes Mellitus | 4 | 2018 | 5889 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2006 | 2892 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2018 | 81762 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 2 | 2023 | 18065 | 0.030 |
Why?
|
Body Mass Index | 4 | 2018 | 13053 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2013 | 5520 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2007 | 4427 | 0.030 |
Why?
|
Glycoproteins | 1 | 2023 | 2202 | 0.030 |
Why?
|
Age Factors | 4 | 2014 | 18412 | 0.030 |
Why?
|
Hypertriglyceridemia | 1 | 2018 | 293 | 0.030 |
Why?
|
Cross-Sectional Studies | 4 | 2020 | 26379 | 0.030 |
Why?
|
Genome, Human | 1 | 2007 | 4446 | 0.030 |
Why?
|
Manometry | 1 | 2017 | 459 | 0.030 |
Why?
|
Cohort Studies | 6 | 2014 | 41754 | 0.030 |
Why?
|
Gene Deletion | 1 | 2021 | 2675 | 0.030 |
Why?
|
Renin | 1 | 2016 | 648 | 0.030 |
Why?
|
Prospective Studies | 5 | 2021 | 54926 | 0.030 |
Why?
|
Cholesterol | 1 | 2023 | 2914 | 0.030 |
Why?
|
Elastic Modulus | 1 | 2013 | 211 | 0.030 |
Why?
|
Transducers, Pressure | 1 | 1992 | 51 | 0.030 |
Why?
|
Recurrence | 1 | 2005 | 8509 | 0.030 |
Why?
|
Electric Impedance | 1 | 2017 | 794 | 0.020 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2013 | 199 | 0.020 |
Why?
|
Morbidity | 1 | 2017 | 1755 | 0.020 |
Why?
|
Oximetry | 1 | 2014 | 462 | 0.020 |
Why?
|
C-Reactive Protein | 2 | 2016 | 3858 | 0.020 |
Why?
|
Heart Function Tests | 1 | 2011 | 317 | 0.020 |
Why?
|
Adult Children | 1 | 2010 | 104 | 0.020 |
Why?
|
Asia | 1 | 2011 | 629 | 0.020 |
Why?
|
Survival Rate | 2 | 2017 | 12840 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 1993 | 1104 | 0.020 |
Why?
|
Thyroid Function Tests | 1 | 2010 | 289 | 0.020 |
Why?
|
Africa | 1 | 2011 | 725 | 0.020 |
Why?
|
Pressure | 1 | 1992 | 1172 | 0.020 |
Why?
|
Parents | 2 | 2014 | 3595 | 0.020 |
Why?
|
Maryland | 1 | 2009 | 278 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 1992 | 1375 | 0.020 |
Why?
|
Emergencies | 1 | 1995 | 1221 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2011 | 590 | 0.020 |
Why?
|
Cardiac Output | 1 | 2011 | 838 | 0.020 |
Why?
|
Pericardium | 1 | 1993 | 679 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5804 | 0.020 |
Why?
|
Hyperthyroidism | 1 | 2010 | 292 | 0.020 |
Why?
|
Dogs | 1 | 1993 | 3845 | 0.020 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2008 | 279 | 0.020 |
Why?
|
Logistic Models | 2 | 2013 | 13290 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2622 | 0.020 |
Why?
|
Overweight | 1 | 2018 | 2448 | 0.020 |
Why?
|
Device Removal | 1 | 2011 | 643 | 0.020 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2012 | 843 | 0.020 |
Why?
|
Hemodynamics | 1 | 2017 | 4194 | 0.020 |
Why?
|
Reference Values | 1 | 2013 | 4938 | 0.020 |
Why?
|
Cardiomegaly | 1 | 2008 | 591 | 0.020 |
Why?
|
Community Health Services | 1 | 2011 | 659 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2013 | 14729 | 0.020 |
Why?
|
Fibrin | 1 | 2008 | 514 | 0.020 |
Why?
|
Hypothyroidism | 1 | 2010 | 667 | 0.020 |
Why?
|
Cause of Death | 1 | 2015 | 3721 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2010 | 2923 | 0.010 |
Why?
|
Streptococcal Infections | 1 | 1989 | 619 | 0.010 |
Why?
|
Europe | 1 | 2011 | 3436 | 0.010 |
Why?
|
Age Distribution | 1 | 2010 | 2873 | 0.010 |
Why?
|
Acute Disease | 1 | 1995 | 7243 | 0.010 |
Why?
|
Coronary Artery Disease | 2 | 2016 | 6568 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2013 | 2819 | 0.010 |
Why?
|
Renin-Angiotensin System | 1 | 2008 | 737 | 0.010 |
Why?
|
Body Weight | 1 | 2014 | 4627 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1992 | 6229 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12168 | 0.010 |
Why?
|
Comorbidity | 1 | 2018 | 10590 | 0.010 |
Why?
|
Pedigree | 1 | 2011 | 4539 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22379 | 0.010 |
Why?
|
Heart Rate | 1 | 2014 | 4214 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2013 | 20227 | 0.010 |
Why?
|
Self Report | 1 | 2014 | 3773 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2008 | 2357 | 0.010 |
Why?
|
Mutation | 1 | 2006 | 30238 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 2010 | 2227 | 0.010 |
Why?
|
Genetic Markers | 1 | 2007 | 2603 | 0.010 |
Why?
|
Medical Records | 1 | 2006 | 1410 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2011 | 2100 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2010 | 2118 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2010 | 2029 | 0.010 |
Why?
|
Family | 1 | 2010 | 3209 | 0.010 |
Why?
|
Aortic Valve | 1 | 1989 | 1970 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2001 | 20760 | 0.010 |
Why?
|
Urban Population | 1 | 2006 | 2046 | 0.010 |
Why?
|
Population Surveillance | 1 | 2008 | 2596 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2011 | 3986 | 0.010 |
Why?
|
Computer Simulation | 1 | 2010 | 6283 | 0.010 |
Why?
|
Survival Analysis | 1 | 2009 | 10101 | 0.010 |
Why?
|
Animals | 2 | 2021 | 169246 | 0.010 |
Why?
|
Genotype | 1 | 2009 | 13045 | 0.010 |
Why?
|
Mice | 1 | 2021 | 82029 | 0.010 |
Why?
|
Phenotype | 1 | 2009 | 16726 | 0.010 |
Why?
|
Stroke | 1 | 2011 | 9755 | 0.010 |
Why?
|
Inflammation | 1 | 2008 | 10873 | 0.000 |
Why?
|